A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the results from two methods used to determine the
renal threshold for glucose excretion (defined as the lowest plasma glucose concentration at
which appreciable amounts of glucose appear in the urine) in untreated patients with type 2
diabetes mellitus and in patients with type 2 diabetes mellitus who are treated with 100 mg
once-daily canigliflozin for 8 days.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.